CN Stock MarketDetailed Quotes

300439 Medicalsystem Biotechnology

Watchlist
  • 8.91
  • -0.14-1.55%
Market Closed Sep 13 15:00 CST
3.42BMarket Cap13.14P/E (TTM)

Medicalsystem Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-2.83%949.13M
-1.91%481.51M
-24.23%1.89B
-22.65%1.47B
-24.32%976.81M
-14.99%490.89M
10.55%2.49B
10.45%1.9B
15.10%1.29B
8.70%577.45M
Operating revenue
-2.83%949.13M
-1.91%481.51M
-24.23%1.89B
-22.65%1.47B
-24.32%976.81M
-14.99%490.89M
10.55%2.49B
10.45%1.9B
15.10%1.29B
8.70%577.45M
Other operating revenue
-6.93%10.52M
----
-32.72%11.01M
----
-1.52%11.3M
----
20.35%16.37M
----
47.50%11.48M
----
Total operating cost
-6.11%783.3M
-4.15%412.34M
-24.70%1.66B
-23.66%1.27B
-25.72%834.29M
-15.26%430.17M
9.64%2.21B
10.22%1.66B
16.04%1.12B
12.33%507.65M
Operating cost
-6.36%507.94M
-6.49%278.01M
-32.14%1.04B
-31.13%810.57M
-32.90%542.45M
-16.53%297.3M
14.87%1.54B
15.73%1.18B
25.22%808.42M
19.46%356.19M
Operating tax surcharges
-1.12%7.96M
5.11%3.98M
24.99%19.15M
41.49%15.89M
10.15%8.05M
12.75%3.79M
-24.14%15.32M
-28.48%11.23M
-39.30%7.31M
10.72%3.36M
Operating expense
-1.41%118.84M
10.60%54.71M
-12.60%262.52M
-11.14%196.05M
-16.88%120.54M
-14.89%49.47M
0.81%300.36M
4.28%220.63M
12.28%145.02M
5.48%58.12M
Administration expense
-11.62%77.1M
-2.10%39.87M
6.98%186.99M
5.70%132.84M
10.56%87.24M
-17.31%40.73M
-1.47%174.79M
-7.81%125.67M
-14.65%78.91M
-9.49%49.25M
Financial expense
-146.53%-4.9M
-1,465.93%-2.53M
-135.60%-1.72M
-212.06%-3.84M
-162.82%-1.99M
-96.51%185.14K
-81.49%4.83M
-81.88%3.42M
-77.23%3.17M
-41.96%5.3M
-Interest expense (Financial expense)
-64.71%1.28M
-77.03%338.36K
-31.79%10.66M
-60.24%4.24M
-57.65%3.62M
-78.60%1.47M
-46.57%15.63M
-49.86%10.67M
-47.21%8.54M
-18.98%6.88M
-Interest Income (Financial expense)
-9.51%-6.33M
-137.47%-2.99M
-77.71%-13.27M
-64.33%-8.18M
-54.99%-5.78M
40.79%-1.26M
-11.57%-7.47M
-25.42%-4.97M
-36.63%-3.73M
-2,624.32%-2.13M
Research and development
-2.09%76.37M
-1.05%38.3M
-12.80%149.8M
-5.75%118.63M
-2.91%78M
9.27%38.7M
14.00%171.78M
14.38%125.87M
7.48%80.34M
10.47%35.42M
Credit Impairment Loss
-91.51%1.95M
-53.00%8.12M
165.42%31.55M
170.17%23.2M
202.63%22.97M
249.32%17.27M
-106.09%-48.23M
-41.18%-33.07M
-84.44%-22.38M
-180.72%-11.56M
Asset Impairment Loss
-238.11%-1.47M
22.38%-747.17K
38.69%-21.27M
18.58%-566.92K
37.22%-433.45K
-348.75%-962.55K
-41.77%-34.69M
90.40%-696.26K
90.22%-690.41K
30.71%-214.49K
Other net revenue
-57.46%21.34M
2.14%15.92M
201.47%54.68M
17,226.97%59.17M
1,349.88%50.17M
42.47%15.59M
-179.45%-53.89M
97.04%-345.46K
186.47%3.46M
386.17%10.94M
Fair value change income
--213.26K
312.39%201.2K
----
----
----
--48.79K
-76.31%165.26K
--779.17K
-47.31%363.61K
----
Invest income
84.99%8.53M
157.26%1.68M
302.09%14.93M
2.09%10.46M
-27.27%4.61M
-132.47%-2.93M
208.43%3.71M
673.15%10.24M
33.20%6.34M
609.95%9.04M
-Including: Investment income associates
-37.24%4.57M
-60.95%1.04M
233.55%16.31M
529.48%13.12M
501.08%7.28M
116.92%2.66M
-220.62%-12.22M
-79.56%2.08M
-138.12%-1.82M
-3.49%1.23M
Asset deal income
101.65%8.58K
103.91%16.9K
-143.23%-782.38K
79.57%-71.68K
-6,492.94%-519.87K
-1,915.90%-432.16K
-167.14%-321.67K
-200.01%-350.9K
-97.43%8.13K
-90.29%23.8K
Other revenue
-48.59%12.1M
155.83%6.66M
18.79%30.26M
14.95%26.15M
18.82%23.54M
-80.95%2.6M
-17.39%25.47M
31.31%22.75M
110.33%19.81M
164.64%13.66M
Operating profit
-2.86%187.17M
11.51%85.09M
22.08%279.12M
9.49%259.65M
12.70%192.68M
-5.49%76.31M
4.07%228.64M
18.48%237.14M
14.43%170.98M
-1.00%80.74M
Add:Non operating Income
987.36%9.01M
244.06%2.47M
19,661.22%19.23M
739.75%5.79M
86.07%828.23K
207.51%717.08K
-91.24%97.33K
-9.63%689.93K
-40.89%445.11K
-44.26%233.19K
Less:Non operating expense
34.24%1.46M
139.40%1.33M
-50.81%2.67M
-54.97%1.74M
-41.78%1.09M
-30.18%553.47K
110.84%5.43M
330.22%3.85M
534.47%1.87M
-20.32%792.73K
Total profit
1.19%194.71M
12.76%86.24M
32.41%295.68M
12.71%263.71M
13.49%192.42M
-4.62%76.47M
2.32%223.31M
16.98%233.98M
13.13%169.55M
-0.99%80.18M
Less:Income tax cost
-27.80%16.38M
19.99%8.18M
99.86%36.18M
16.39%40.07M
-11.64%22.69M
-44.16%6.82M
-35.54%18.1M
3.13%34.42M
7.02%25.68M
21.59%12.22M
Net profit
5.06%178.33M
12.06%78.05M
26.46%259.5M
12.07%223.64M
17.98%169.73M
2.48%69.65M
7.92%205.2M
19.75%199.56M
14.29%143.87M
-4.19%67.97M
Net profit from continuing operation
5.06%178.33M
12.06%78.05M
26.46%259.5M
12.07%223.64M
17.98%169.73M
2.48%69.65M
7.92%205.2M
19.75%199.56M
14.29%143.87M
-4.19%67.97M
Less:Minority Profit
97.32%-137.58K
40.63%-1.04M
-55.84%2.95M
-62.61%-6.31M
-91.95%-5.14M
-10.33%-1.76M
-37.39%6.68M
35.34%-3.88M
62.67%-2.68M
65.38%-1.59M
Net profit of parent company owners
2.06%178.46M
10.76%79.1M
29.23%256.55M
13.03%229.96M
19.33%174.87M
2.66%71.41M
10.61%198.53M
17.83%203.44M
10.15%146.55M
-7.92%69.56M
Earning per share
Basic earning per share
1.80%0.4648
10.53%0.21
28.85%0.67
13.03%0.6004
19.34%0.4566
5.56%0.19
8.33%0.52
13.75%0.5312
4.39%0.3826
-14.29%0.18
Diluted earning per share
1.80%0.4648
10.53%0.21
28.85%0.67
13.03%0.6004
19.34%0.4566
5.56%0.19
8.33%0.52
13.75%0.5312
4.39%0.3826
-14.29%0.18
Other composite income
-292.31%-5.24M
-97.04%20.52K
-182.16%-4.74M
81.29%-1.15M
50.85%-1.34M
147.32%694.17K
-1,511.80%-1.68M
-441.19%-6.17M
-161.04%-2.72M
120.55%280.68K
Other composite income of parent company owners
-1,800.60%-3.64M
-87.44%22.34K
-541.92%-4.01M
92.99%-206.24K
84.90%-191.59K
36.30%177.83K
224.51%906.51K
-139.41%-2.94M
-4.33%-1.27M
110.85%130.47K
Other composite income of minority owners
-39.97%-1.6M
-100.35%-1.82K
71.48%-738.18K
70.60%-947.77K
21.05%-1.15M
243.76%516.34K
-514.89%-2.59M
-3,680.67%-3.22M
-930.73%-1.45M
192.00%150.21K
Total composite income
2.78%173.08M
10.98%78.07M
25.17%254.76M
15.05%222.49M
19.30%168.39M
3.08%70.35M
7.09%203.52M
16.85%193.39M
13.07%141.15M
-1.90%68.25M
Total composite income of parent company owners
0.08%174.82M
10.52%79.12M
26.63%252.55M
14.59%229.75M
20.24%174.67M
2.73%71.59M
11.56%199.43M
16.96%200.5M
10.20%145.28M
-6.25%69.69M
Total composite income of minority owners
72.29%-1.74M
15.83%-1.05M
-45.95%2.21M
-2.18%-7.26M
-52.23%-6.28M
13.94%-1.24M
-63.77%4.09M
-20.16%-7.11M
41.00%-4.13M
69.71%-1.44M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -2.83%949.13M-1.91%481.51M-24.23%1.89B-22.65%1.47B-24.32%976.81M-14.99%490.89M10.55%2.49B10.45%1.9B15.10%1.29B8.70%577.45M
Operating revenue -2.83%949.13M-1.91%481.51M-24.23%1.89B-22.65%1.47B-24.32%976.81M-14.99%490.89M10.55%2.49B10.45%1.9B15.10%1.29B8.70%577.45M
Other operating revenue -6.93%10.52M-----32.72%11.01M-----1.52%11.3M----20.35%16.37M----47.50%11.48M----
Total operating cost -6.11%783.3M-4.15%412.34M-24.70%1.66B-23.66%1.27B-25.72%834.29M-15.26%430.17M9.64%2.21B10.22%1.66B16.04%1.12B12.33%507.65M
Operating cost -6.36%507.94M-6.49%278.01M-32.14%1.04B-31.13%810.57M-32.90%542.45M-16.53%297.3M14.87%1.54B15.73%1.18B25.22%808.42M19.46%356.19M
Operating tax surcharges -1.12%7.96M5.11%3.98M24.99%19.15M41.49%15.89M10.15%8.05M12.75%3.79M-24.14%15.32M-28.48%11.23M-39.30%7.31M10.72%3.36M
Operating expense -1.41%118.84M10.60%54.71M-12.60%262.52M-11.14%196.05M-16.88%120.54M-14.89%49.47M0.81%300.36M4.28%220.63M12.28%145.02M5.48%58.12M
Administration expense -11.62%77.1M-2.10%39.87M6.98%186.99M5.70%132.84M10.56%87.24M-17.31%40.73M-1.47%174.79M-7.81%125.67M-14.65%78.91M-9.49%49.25M
Financial expense -146.53%-4.9M-1,465.93%-2.53M-135.60%-1.72M-212.06%-3.84M-162.82%-1.99M-96.51%185.14K-81.49%4.83M-81.88%3.42M-77.23%3.17M-41.96%5.3M
-Interest expense (Financial expense) -64.71%1.28M-77.03%338.36K-31.79%10.66M-60.24%4.24M-57.65%3.62M-78.60%1.47M-46.57%15.63M-49.86%10.67M-47.21%8.54M-18.98%6.88M
-Interest Income (Financial expense) -9.51%-6.33M-137.47%-2.99M-77.71%-13.27M-64.33%-8.18M-54.99%-5.78M40.79%-1.26M-11.57%-7.47M-25.42%-4.97M-36.63%-3.73M-2,624.32%-2.13M
Research and development -2.09%76.37M-1.05%38.3M-12.80%149.8M-5.75%118.63M-2.91%78M9.27%38.7M14.00%171.78M14.38%125.87M7.48%80.34M10.47%35.42M
Credit Impairment Loss -91.51%1.95M-53.00%8.12M165.42%31.55M170.17%23.2M202.63%22.97M249.32%17.27M-106.09%-48.23M-41.18%-33.07M-84.44%-22.38M-180.72%-11.56M
Asset Impairment Loss -238.11%-1.47M22.38%-747.17K38.69%-21.27M18.58%-566.92K37.22%-433.45K-348.75%-962.55K-41.77%-34.69M90.40%-696.26K90.22%-690.41K30.71%-214.49K
Other net revenue -57.46%21.34M2.14%15.92M201.47%54.68M17,226.97%59.17M1,349.88%50.17M42.47%15.59M-179.45%-53.89M97.04%-345.46K186.47%3.46M386.17%10.94M
Fair value change income --213.26K312.39%201.2K--------------48.79K-76.31%165.26K--779.17K-47.31%363.61K----
Invest income 84.99%8.53M157.26%1.68M302.09%14.93M2.09%10.46M-27.27%4.61M-132.47%-2.93M208.43%3.71M673.15%10.24M33.20%6.34M609.95%9.04M
-Including: Investment income associates -37.24%4.57M-60.95%1.04M233.55%16.31M529.48%13.12M501.08%7.28M116.92%2.66M-220.62%-12.22M-79.56%2.08M-138.12%-1.82M-3.49%1.23M
Asset deal income 101.65%8.58K103.91%16.9K-143.23%-782.38K79.57%-71.68K-6,492.94%-519.87K-1,915.90%-432.16K-167.14%-321.67K-200.01%-350.9K-97.43%8.13K-90.29%23.8K
Other revenue -48.59%12.1M155.83%6.66M18.79%30.26M14.95%26.15M18.82%23.54M-80.95%2.6M-17.39%25.47M31.31%22.75M110.33%19.81M164.64%13.66M
Operating profit -2.86%187.17M11.51%85.09M22.08%279.12M9.49%259.65M12.70%192.68M-5.49%76.31M4.07%228.64M18.48%237.14M14.43%170.98M-1.00%80.74M
Add:Non operating Income 987.36%9.01M244.06%2.47M19,661.22%19.23M739.75%5.79M86.07%828.23K207.51%717.08K-91.24%97.33K-9.63%689.93K-40.89%445.11K-44.26%233.19K
Less:Non operating expense 34.24%1.46M139.40%1.33M-50.81%2.67M-54.97%1.74M-41.78%1.09M-30.18%553.47K110.84%5.43M330.22%3.85M534.47%1.87M-20.32%792.73K
Total profit 1.19%194.71M12.76%86.24M32.41%295.68M12.71%263.71M13.49%192.42M-4.62%76.47M2.32%223.31M16.98%233.98M13.13%169.55M-0.99%80.18M
Less:Income tax cost -27.80%16.38M19.99%8.18M99.86%36.18M16.39%40.07M-11.64%22.69M-44.16%6.82M-35.54%18.1M3.13%34.42M7.02%25.68M21.59%12.22M
Net profit 5.06%178.33M12.06%78.05M26.46%259.5M12.07%223.64M17.98%169.73M2.48%69.65M7.92%205.2M19.75%199.56M14.29%143.87M-4.19%67.97M
Net profit from continuing operation 5.06%178.33M12.06%78.05M26.46%259.5M12.07%223.64M17.98%169.73M2.48%69.65M7.92%205.2M19.75%199.56M14.29%143.87M-4.19%67.97M
Less:Minority Profit 97.32%-137.58K40.63%-1.04M-55.84%2.95M-62.61%-6.31M-91.95%-5.14M-10.33%-1.76M-37.39%6.68M35.34%-3.88M62.67%-2.68M65.38%-1.59M
Net profit of parent company owners 2.06%178.46M10.76%79.1M29.23%256.55M13.03%229.96M19.33%174.87M2.66%71.41M10.61%198.53M17.83%203.44M10.15%146.55M-7.92%69.56M
Earning per share
Basic earning per share 1.80%0.464810.53%0.2128.85%0.6713.03%0.600419.34%0.45665.56%0.198.33%0.5213.75%0.53124.39%0.3826-14.29%0.18
Diluted earning per share 1.80%0.464810.53%0.2128.85%0.6713.03%0.600419.34%0.45665.56%0.198.33%0.5213.75%0.53124.39%0.3826-14.29%0.18
Other composite income -292.31%-5.24M-97.04%20.52K-182.16%-4.74M81.29%-1.15M50.85%-1.34M147.32%694.17K-1,511.80%-1.68M-441.19%-6.17M-161.04%-2.72M120.55%280.68K
Other composite income of parent company owners -1,800.60%-3.64M-87.44%22.34K-541.92%-4.01M92.99%-206.24K84.90%-191.59K36.30%177.83K224.51%906.51K-139.41%-2.94M-4.33%-1.27M110.85%130.47K
Other composite income of minority owners -39.97%-1.6M-100.35%-1.82K71.48%-738.18K70.60%-947.77K21.05%-1.15M243.76%516.34K-514.89%-2.59M-3,680.67%-3.22M-930.73%-1.45M192.00%150.21K
Total composite income 2.78%173.08M10.98%78.07M25.17%254.76M15.05%222.49M19.30%168.39M3.08%70.35M7.09%203.52M16.85%193.39M13.07%141.15M-1.90%68.25M
Total composite income of parent company owners 0.08%174.82M10.52%79.12M26.63%252.55M14.59%229.75M20.24%174.67M2.73%71.59M11.56%199.43M16.96%200.5M10.20%145.28M-6.25%69.69M
Total composite income of minority owners 72.29%-1.74M15.83%-1.05M-45.95%2.21M-2.18%-7.26M-52.23%-6.28M13.94%-1.24M-63.77%4.09M-20.16%-7.11M41.00%-4.13M69.71%-1.44M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data